시장보고서
상품코드
1338938

초붕해제 시장, 점유율, 규모, 동향 및 산업 분석 보고서 : 제품별, 제형별, 치료 영역별, 지역별, 부문별 예측(2023-2032년)

Superdisintegrants Market Share, Size, Trends, Industry Analysis Report, By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin); By Formulation; By Therapeutic Area; By Region; Segment Forecast, 2023-2032

발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 114 Pages | 배송안내 : 1-2일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 세계 초붕해제 시장 규모는 2032년까지 8억 2,954만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.

심혈관 질환, 당뇨병, 암과 같은 만성 질환의 유병률이 증가함에 따라 의약품에 대한 수요가 증가하고 있습니다. 초붕해제는 이러한 의약품의 제형에 중요한 역할을 하고 있으며, 제약 산업에서 없어서는 안 될 필수 성분으로 자리 잡고 있습니다. 비감염성 질환(NCD)으로 인한 사망자 수는 연간 1,790만 명으로 가장 많으며, 심혈관 질환(930만 명), 만성 호흡기 질환(410만 명), 당뇨병(120만 명)(당뇨병으로 인한 신장 질환으로 인한 사망자 포함 200만 명)이 그 뒤를 잇고 있습니다. 이는 향후 몇 년간 시장 성장의 원동력이 될 것으로 보입니다.

기술의 발전으로 보다 효율적인 새로운 초붕해제의 개발이 진행되고 있습니다. 예를 들어, 최근 연구에 따르면 바나나 분말을 정제 및 캡슐을 포함한 다양한 의약품 제형에 초붕해제로 사용하는 것이 연구되고 있습니다. 이로 인해 여러 의약품의 제형에서 이러한 부형제의 사용이 증가하고 있습니다. 제네릭 의약품은 저렴한 가격으로 쉽게 구할 수 있기 때문에 수요가 증가하고 있습니다.

제약 산업에서 초붕해제 사용이 증가하고 새롭고 혁신적인 솔루션에 대한 특허 출원 건수가 증가하면서 초붕해제 시장의 성장을 가속하고 있습니다. 미국 국립표준기술연구소(NIST)와 유엔특허상표청(USPTO)의 데이터를 종합하면 N-비닐피롤리돈 전분 글리콜산나트륨은 15건의 특허를 보유하고 있으며, 그 뒤를 이어 아밀로스가 14건의 특허를 보유하고 있습니다. 제약회사들이 보다 효율적이고 효과적인 약물 전달 시스템을 개발하기 위해 노력하는 가운데 이러한 추세는 앞으로도 계속될 것으로 예상됩니다.

초붕해제 시장 보고서 하이라이트

크로스포비돈 분야는 속용성 제형에 대한 수요 증가로 성장이 예상됩니다.

정제는 제약업계에서 가장 많이 사용되는 제형이며, 초붕해제는 정제 제제의 중요한 성분이기 때문에 정제 분야가 가장 높은 성장률을 보이고 있습니다.

소화기 질환은 소화기 질환의 유병률 증가와 환자 중심의 약물 전달에 대한 관심이 높아짐에 따라 괄목할 만한 성장률을 보일 것으로 예상됩니다.

북미는 만성질환 유병률의 급격한 증가와 기술 발전으로 인해 가장 큰 매출 점유율을 차지할 것으로 예상됩니다.

APAC은 중국, 인도와 같은 개발도상국의 제약 산업 성장으로 인해 향후 몇 년동안 큰 성장률을 보일 것으로 예상됩니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 초붕해제 시장에 관한 통찰

  • 초붕해제 시장 - 치료 영역 현황
  • 초붕해제 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • PESTEL 분석
  • 초붕해제 시장 치료 영역 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 초붕해제 시장, 제품별

  • 주요 조사 결과
  • 서론
  • 변성전분
  • 변성 셀룰로오스
  • 크로스포비돈
  • 이온교환수지

제6장 세계의 초붕해제 시장, 제형별

  • 주요 조사 결과
  • 서론
  • 태블릿
  • 캡슐

제7장 세계의 초붕해제 시장, 치료 영역별

  • 주요 조사 결과
  • 서론
  • 소화기 질환
  • 신경질환
  • 종양학
  • 감염증
  • 심혈관질환
  • 혈액 질환
  • 염증성 질환

제8장 세계의 초붕해제 시장, 지역별

  • 주요 조사 결과
  • 서론
    • 초붕해제 시장 평가, 지역, 2019-2032년
  • 초붕해제 시장 - 북미
    • 북미 : 초붕해제 시장, 제품별, 2019-2032년
    • 북미 : 초붕해제 시장, 치료 영역별, 2019-2032년
    • 북미 : 초붕해제 시장, 제형별, 2019-2032년
    • 초붕해제 시장 - 미국
    • 초붕해제 시장 - 캐나다
  • 초붕해제 시장 - 유럽
    • 유럽 : 초붕해제 시장, 제품별, 2019-2032년
    • 유럽 : 초붕해제 시장, 치료 영역별, 2019-2032년
    • 유럽 : 초붕해제 시장, 제형별, 2019-2032년
    • 초붕해제 시장 - 영국
    • 초붕해제 시장 - 프랑스
    • 초붕해제 시장 - 독일
    • 초붕해제 시장 - 이탈리아
    • 초붕해제 시장 - 스페인
    • 초붕해제 시장 - 네덜란드
    • 초붕해제 시장 - 러시아
  • 초붕해제 시장 - 아시아태평양
    • 아시아태평양 : 초붕해제 시장, 제품별, 2019-2032년
    • 아시아태평양 : 초붕해제 시장, 치료 영역별, 2019-2032년
    • 아시아태평양 : 초붕해제 시장, 제형별, 2019-2032년
    • 초붕해제 시장 - 중국
    • 초붕해제 시장 - 인도
    • 초붕해제 시장 - 말레이시아
    • 초붕해제 시장 - 일본
    • 초붕해제 시장 - 인도네시아
    • 초붕해제 시장 - 한국
  • 초붕해제 시장 - 중동 및 아프리카
    • 중동 및 아프리카 : 초붕해제 시장, 제품별, 2019-2032년
    • 중동 및 아프리카 : 초붕해제 시장, 치료 영역별, 2019-2032년
    • 중동 및 아프리카 : 초붕해제 시장, 제형별, 2019-2032년
    • 초붕해제 시장 - 사우디아라비아
    • 초붕해제 시장 - 아랍에미리트(UAE)
    • 초붕해제 시장 - 이스라엘
    • 초붕해제 시장 - 남아프리카
  • 초붕해제 시장 - 라틴아메리카
    • 라틴아메리카 : 초붕해제 시장, 제품별, 2019-2032년
    • 라틴아메리카 : 초붕해제 시장, 치료 영역별, 2019-2032년
    • 라틴아메리카 : 초붕해제 시장, 제형별, 2019-2032년
    • 초붕해제 시장 - 멕시코
    • 초붕해제 시장 - 브라질
    • 초붕해제 시장 - 아르헨티나

제9장 경쟁 구도

  • 확장 및 인수 분석
    • 확장
    • 인수
  • 제휴/협업/합의/공개

제10장 기업 개요

  • BASF
  • Roquette Freres
  • Ashland Global
  • Dow DuPont
  • DFE Pharma
  • Asahi Kasei
  • Merck
  • Corel Pharma & Avantor Performance.
LSH 23.09.15

The global superdisintegrants market size is expected to reach USD 829.54 million by 2032, according to a new study by Polaris Market Research. The report "Superdisintegrants Market Share, Size, Trends, Industry Analysis Report, By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin); By Formulation; By Therapeutic Area; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, and cancer has increased the demand for drugs. Superdisintegrants play a vital role in formulating these drugs, making them essential components in the pharmaceutical industry. The most non-communicable disease deaths (NCD), 17.9 million per year, are caused by cardiovascular diseases, followed by cancer (9.3 million), chronic respiratory conditions (4.1 million), and diabetes (1.2 million) (2.0 million, including fatalities from renal disease brought on by diabetes)). This will drive the growth of the market in the upcoming years.

Advancements in technology have led to the development of new and more efficient super disintegrants. For instance, recent studies have investigated using banana powder as a super disintegrant in various pharmaceutical formulations, including tablets and capsules. This has led to increased use of these excipients in formulating multiple drugs. The demand for generic drugs is rising due to their affordability and accessibility.

The increasing use of super disintegrants in the pharmaceutical industry, coupled with the growing number of patents being filed for new and innovative solutions, is driving the growth of the super disintegrants market. According to the combination of data from the National Institute of Standards & Technology (NIST) and the United Nations Patent and Trademark Office (USPTO), N-Vinyl pyrrolidone+sodium starch glycolate has 15 patents, followed by Amylose with 14 patents. This trend is expected to continue in the coming years as drug manufacturers seek to develop more efficient and effective drug delivery systems.

Superdisintegrants Market Report Highlights

Crospovidone segment is anticipated to grow due to increasing demand for fast dissolving dosage forms.

Tablets segment is registered the highest growth rate owing to the as tablets are the most used dosage form in the pharmaceutical industry and superdisintegrants are critical ingredients in tablet formulations.

Gastrointestinal diseases are projected to experience significant growth rate due to the growing incidence of GI disorders and increased focus on patient-centric drug delivery.

North America is expected to have the largest revenue share owing to the strong increasing incidence of chronic diseases and technological advancements.

APAC is projected to witness significant growth rate in the coming years due to the growing pharmaceutical industry in developing countries like China and India.

The global players include: BASF, Ashland Global, Dow DuPont, Roquette Freres, DFE Pharma, JRS PHARMA, Asahi Kasei, Merck, Corel Pharma & Avantor Performance.

Polaris Market Research has segmented the superdisintegrants market report based on product, formulation, therapeutic area, and region:

Superdisintegrants, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • Modified Starch
  • Modified Cellulose
  • Crospovidone
  • Ion Exchange Resin

Superdisintegrants, Formulation Outlook (Revenue - USD Million, 2019 - 2032)

  • Tablets
  • Capsules

Superdisintegrants, Therapeutic area Outlook (Revenue - USD Million, 2019 - 2032)

  • Gastrointestinal Diseases
  • Neurological Diseases
  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Hematological Diseases
  • Inflammatory Diseases

Superdisintegrants, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Superdisintegrants Market Insights

  • 4.1. Superdisintegrants Market - Therapeutic Area Snapshot
  • 4.2. Superdisintegrants Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Adoption of Orally Disintegrating Tablets
      • 4.2.1.2. Growing Generics Market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Safety and Quality Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Superdisintegrants Market Therapeutic Area Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Superdisintegrants Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • 5.3. Modified Starch
    • 5.3.1. Global Superdisintegrants Market, by Modified Starch, by Region, 2019-2032 (USD Million)
  • 5.4. Modified Cellulose
    • 5.4.1. Global Superdisintegrants Market, by Modified Cellulose, by Region, 2019-2032 (USD Million)
  • 5.5. Crospovidone
    • 5.5.1. Global Superdisintegrants Market, by Crospovidone, by Region, 2019-2032 (USD Million)
  • 5.6. Ion Exchange Resin
    • 5.6.1. Global Superdisintegrants Market, by Ion Exchange Resin, by Region, 2019-2032 (USD Million)

6. Global Superdisintegrants Market, by Formulation

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 6.3. Tablets
    • 6.3.1. Global Superdisintegrants Market, by Tablets by Region, 2019-2032 (USD Million)
  • 6.4. Capsules
    • 6.4.1. Global Superdisintegrants Market, by Capsules, by Region, 2019-2032 (USD Million)

7. Global Superdisintegrants Market, by Therapeutic Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • 7.3. Gastrointestinal Diseases
    • 7.3.1. Global Superdisintegrants Market, by Gastrointestinal Diseases, By Region, 2019-2032 (USD Million)
  • 7.4. Neurological Diseases
    • 7.4.1. Global Superdisintegrants Market, by Neurological Diseases, By Region, 2019-2032 (USD Million)
  • 7.5. Oncology
    • 7.5.1. Global Superdisintegrants Market, by Oncology, By Region, 2019-2032 (USD Million)
  • 7.6. Infectious Diseases
    • 7.6.1. Global Superdisintegrants Market, by Infectious Diseases, By Region, 2019-2032 (USD Million)
  • 7.7. Cardiovascular Diseases
    • 7.7.1. Global Superdisintegrants Market, by Cardiovascular Diseases, By Region, 2019-2032 (USD Million)
  • 7.8. Hematological Diseases
    • 7.8.1. Global Superdisintegrants Market, by Hematological Diseases, By Region, 2019-2032 (USD Million)
  • 7.9. Inflammatory Diseases
    • 7.9.1. Global Superdisintegrants Market, by Inflammatory Diseases, By Region, 2019-2032 (USD Million)

8. Global Superdisintegrants Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Superdisintegrants Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Superdisintegrants Market - North America
    • 8.3.1. North America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.3.2. North America: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.3.3. North America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.3.4. Superdisintegrants Market - U.S.
      • 8.3.4.1. U.S.: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.3.5. Superdisintegrants Market - Canada
      • 8.3.5.1. Canada: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.4. Superdisintegrants Market - Europe
    • 8.4.1. Europe: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.4.3. Europe: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.4. Superdisintegrants Market - UK
      • 8.4.4.1. UK: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.5. Superdisintegrants Market - France
      • 8.4.5.1. France: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.5.3. France: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.6. Superdisintegrants Market - Germany
      • 8.4.6.1. Germany: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.7. Superdisintegrants Market - Italy
      • 8.4.7.1. Italy: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.8. Superdisintegrants Market - Spain
      • 8.4.8.1. Spain: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.9. Superdisintegrants Market - Netherlands
      • 8.4.9.1. Netherlands: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.10. Superdisintegrants Market - Russia
      • 8.4.10.1. Russia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.5. Superdisintegrants Market - Asia Pacific
    • 8.5.1. Asia Pacific: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.4. Superdisintegrants Market - China
      • 8.5.4.1. China: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.4.3. China: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.5. Superdisintegrants Market - India
      • 8.5.5.1. India: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.5.3. India: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.6. Superdisintegrants Market - Malaysia
      • 8.5.6.1. Malaysia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.7. Superdisintegrants Market - Japan
      • 8.5.7.1. Japan: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.8. Superdisintegrants Market - Indonesia
      • 8.5.8.1. Indonesia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.9. Superdisintegrants Market - South Korea
      • 8.5.9.1. South Korea: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.6. Superdisintegrants Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.4. Superdisintegrants Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.5. Superdisintegrants Market - UAE
      • 8.6.5.1. UAE: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.6. Superdisintegrants Market - Israel
      • 8.6.6.1. Israel: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.7. Superdisintegrants Market - South Africa
      • 8.6.7.1. South Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.7. Superdisintegrants Market - Latin America
    • 8.7.1. Latin America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.7.4. Superdisintegrants Market - Mexico
      • 8.7.4.1. Mexico: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.7.5. Superdisintegrants Market - Brazil
      • 8.7.5.1. Brazil: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.7.6. Superdisintegrants Market - Argentina
      • 8.7.6.1. Argentina: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. BASF
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Roquette Freres
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Ashland Global
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Dow DuPont
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. DFE Pharma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Asahi Kasei
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Merck
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Corel Pharma & Avantor Performance.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제